Literature DB >> 30619678

Repurposing Human Osteoarthritic Cartilage as a Bone Graft Substitute in an Athymic Rat Posterolateral Spinal Fusion Model.

Alan B C Dang1,2, Helena Hong3, Katie Lee2, Tammy Luan1, Sanjay Reddy1, Alfred C Kuo1,2.   

Abstract

BACKGROUND: Spinal fusion involves both endochondral and intramembranous bone formation. We previously demonstrated that endochondral cartilage grafts that were derived from human osteoarthritic (OA) articular cartilage can be used as a bone graft in mouse models. We hypothesized that OA cartilage could also be recycled and repurposed as a bone graft substitute in a posterolateral lumbar spinal fusion model in athymic rats.
METHODS: OA articular cartilage was obtained from the femoral resection of a healthy 60-year-old man undergoing elective total knee arthroplasty. The chondrocytes recovered from this tissue were dedifferentiated in monolayer tissue culture and then transitioned to culture conditions that promote chondrocyte hypertrophy. The resultant cell pellets were then used as bone graft substitute for single-level posterolateral spinal fusion in 5 athymic rats. Decortication alone was used as the control group. Spinal fusion was assessed with manual palpation, micro-computed tomography, and histologic analysis.
RESULTS: In the experimental group, micro-computed tomography at 4 and 8 weeks demonstrated bilateral fusion in 4 of 5 animals and unilateral fusion in 1 animal. At 8 weeks, manual palpation and histologic analysis showed direct correlation with the radiographic findings. Animals undergoing decortication alone failed to generate any spinal fusion. The difference in the fusion rate between groups was statistically significant with respect to both unilateral fusion (P = .047) and bilateral fusion (P = .007).
CONCLUSIONS: In the absence of additional surgically implanted bone graft, hypertrophic chondrocyte grafts are sufficient for generating single-level posterolateral lumbar fusion in athymic rats. CLINICAL RELEVANCE: This animal study demonstrates that cartilage harvested from OA knees can be used as a bone graft substitute. Commercially available cell-based bone grafts have previously only used mesenchymal stem cells or osteoblast precursor cells.

Entities:  

Keywords:  animal models; endochondral bone formation; spinal fusion

Year:  2018        PMID: 30619678      PMCID: PMC6314337          DOI: 10.14444/5092

Source DB:  PubMed          Journal:  Int J Spine Surg        ISSN: 2211-4599


  30 in total

1.  Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo.

Authors:  M Viggeswarapu; S D Boden; Y Liu; G A Hair; J Louis-Ugbo; H Murakami; H S Kim; M T Mayr; W C Hutton; L Titus
Journal:  J Bone Joint Surg Am       Date:  2001-03       Impact factor: 5.284

Review 2.  Regional gene therapy to enhance bone repair.

Authors:  A W A Baltzer; J R Lieberman
Journal:  Gene Ther       Date:  2004-02       Impact factor: 5.250

3.  Outcome of local bone versus autogenous iliac crest bone graft in the instrumented posterolateral fusion of the lumbar spine.

Authors:  Dilip K Sengupta; Eeric Truumees; Chetan K Patel; Chris Kazmierczak; Brian Hughes; Greg Elders; Harry N Herkowitz
Journal:  Spine (Phila Pa 1976)       Date:  2006-04-20       Impact factor: 3.468

Review 4.  Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector.

Authors:  Peter Manilla; Tessio Rebello; Cathleen Afable; Xiaobin Lu; Vladimir Slepushkin; Laurent M Humeau; Kathy Schonely; Yajin Ni; Gwendolyn K Binder; Bruce L Levine; Rob-Roy MacGregor; Carl H June; Boro Dropulic
Journal:  Hum Gene Ther       Date:  2005-01       Impact factor: 5.695

5.  Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.

Authors:  Jeffrey C Wang; Linda E A Kanim; Stephen Yoo; Patricia A Campbell; Arnold J Berk; Jay R Lieberman
Journal:  J Bone Joint Surg Am       Date:  2003-05       Impact factor: 5.284

6.  Is local bone viable as a source of bone graft in posterior lumbar interbody fusion?

Authors:  Yasushi Miura; Shiro Imagama; Masaki Yoda; Hideyuki Mitsuguchi; Hiroaki Kachi
Journal:  Spine (Phila Pa 1976)       Date:  2003-10-15       Impact factor: 3.468

Review 7.  Complications of revision spinal surgery.

Authors:  Kurt M Eichholz; Timothy C Ryken
Journal:  Neurosurg Focus       Date:  2003-09-15       Impact factor: 4.047

8.  Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2).

Authors:  David A Wong; Anant Kumar; Sanjay Jatana; Gary Ghiselli; Katherine Wong
Journal:  Spine J       Date:  2007-11-26       Impact factor: 4.166

9.  Comparison of posterolateral lumbar fusion rates of Grafton Putty and OP-1 Putty in an athymic rat model.

Authors:  David A Bomback; Jonathan N Grauer; Roberto Lugo; Nancy Troiano; Tushar Ch Patel; Gary E Friedlaender
Journal:  Spine (Phila Pa 1976)       Date:  2004-08-01       Impact factor: 3.468

10.  Posterolateral lumbar fusions in athymic rats: characterization of a model.

Authors:  Jonathan N Grauer; David A Bomback; Roberto Lugo; Nancy W Troiano; Tushar C Patel; Gary E Friedlaender
Journal:  Spine J       Date:  2004 May-Jun       Impact factor: 4.166

View more
  3 in total

1.  Locally Delivered Ascorbic Acid and β-Glycerophosphate Augment Local Bone Graft in a Murine Model of 2-Level Posterior Spinal Fusion.

Authors:  Joshua Vic Chen; Katie Lee; Kyle Tillinghast; Bernard Halloran; Alan B C Dang
Journal:  Int J Spine Surg       Date:  2021-10-14

2.  A timeseries analysis of the fracture callus extracellular matrix proteome during bone fracture healing.

Authors:  Christopher B Erickson; Ryan Hill; Donna Pascablo; Galateia Kazakia; Kirk Hansen; Chelsea Bahney
Journal:  J Life Sci (Westlake Village)       Date:  2021-12

3.  A Composite Lactide-Mineral 3D-Printed Scaffold for Bone Repair and Regeneration.

Authors:  Rayan Fairag; Li Li; Jose Luis Ramirez-GarciaLuna; M Scott Taylor; Brian Gaerke; Michael H Weber; Derek H Rosenzweig; Lisbet Haglund
Journal:  Front Cell Dev Biol       Date:  2021-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.